<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK431123" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK431123/" /><meta name="ncbi_pagename" content="SLC39A14 Deficiency - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>SLC39A14 Deficiency - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="SLC39A14 Deficiency" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2017/05/25" /><meta name="citation_author" content="Karin Tuschl" /><meta name="citation_author" content="Allison Gregory" /><meta name="citation_author" content="Esther Meyer" /><meta name="citation_author" content="Peter T Clayton" /><meta name="citation_author" content="Susan J Hayflick" /><meta name="citation_author" content="Philippa B Mills" /><meta name="citation_author" content="Manju A Kurian" /><meta name="citation_pmid" content="28541650" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK431123/" /><meta name="citation_keywords" content="SLC39A14-Related Early-Onset Dystonia-Parkinsonism" /><meta name="citation_keywords" content="SLC39A14-Related Early-Onset Dystonia-Parkinsonism" /><meta name="citation_keywords" content="Zinc transporter ZIP14" /><meta name="citation_keywords" content="SLC39A14" /><meta name="citation_keywords" content="SLC39A14 Deficiency" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="SLC39A14 Deficiency" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Karin Tuschl" /><meta name="DC.Contributor" content="Allison Gregory" /><meta name="DC.Contributor" content="Esther Meyer" /><meta name="DC.Contributor" content="Peter T Clayton" /><meta name="DC.Contributor" content="Susan J Hayflick" /><meta name="DC.Contributor" content="Philippa B Mills" /><meta name="DC.Contributor" content="Manju A Kurian" /><meta name="DC.Date" content="2017/05/25" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK431123/" /><meta name="description" content="SLC39A14 deficiency is characterized by evidence between ages six months and three years of delay or loss of motor developmental milestones (e.g., delayed walking, gait disturbance). Early in the disease course, children show axial hypotonia followed by dystonia, spasticity, dysarthria, bulbar dysfunction, and signs of parkinsonism including bradykinesia, hypomimia, and tremor. By the end of the first decade they develop severe, generalized, pharmaco-resistant dystonia, limb contractures, and scoliosis, and lose independent ambulation. Cognitive impairment appears to be less prominent than motor disability. Some affected children have succumbed in their first decade due to secondary complications such as respiratory infections." /><meta name="og:title" content="SLC39A14 Deficiency" /><meta name="og:type" content="book" /><meta name="og:description" content="SLC39A14 deficiency is characterized by evidence between ages six months and three years of delay or loss of motor developmental milestones (e.g., delayed walking, gait disturbance). Early in the disease course, children show axial hypotonia followed by dystonia, spasticity, dysarthria, bulbar dysfunction, and signs of parkinsonism including bradykinesia, hypomimia, and tremor. By the end of the first decade they develop severe, generalized, pharmaco-resistant dystonia, limb contractures, and scoliosis, and lose independent ambulation. Cognitive impairment appears to be less prominent than motor disability. Some affected children have succumbed in their first decade due to secondary complications such as respiratory infections." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK431123/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/slc39a14-def/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK431123/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE88D9D1E040B7A10000000001BB00A2.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK431123_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK431123_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/slc12a5-e/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/slc6a3-dtds/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK431123_"><span class="title" itemprop="name">SLC39A14 Deficiency</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: <i>SLC39A14</i>-Related Early-Onset Dystonia-Parkinsonism</div><p class="contrib-group"><span itemprop="author">Karin Tuschl</span>, MD, <span itemprop="author">Allison Gregory</span>, MS, CGC, <span itemprop="author">Esther Meyer</span>, PhD, <span itemprop="author">Peter T Clayton</span>, MD, <span itemprop="author">Susan J Hayflick</span>, MD, <span itemprop="author">Philippa B Mills</span>, PhD, and <span itemprop="author">Manju A Kurian</span>, PhD.</p><a data-jig="ncbitoggler" href="#__NBK431123_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK431123_ai__"><div class="contrib half_rhythm"><span itemprop="author">Karin Tuschl</span>, MD<div class="affiliation small">UCL Great Ormond Street Institute of Child Health<br />King's College London<br />London, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.lcu@lhcsut.k" class="oemail">ku.ca.lcu@lhcsut.k</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Allison Gregory</span>, MS, CGC<div class="affiliation small">Oregon Health and Science University<br />Portland, Oregon<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.usho@ayrogerg" class="oemail">ude.usho@ayrogerg</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Esther Meyer</span>, PhD<div class="affiliation small">UCL Great Ormond Street Institute of Child Health<br />King's College London<br />London, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.shn.tbn@reyem.rehtse" class="oemail">ku.shn.tbn@reyem.rehtse</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Peter T Clayton</span>, MD<div class="affiliation small">UCL Great Ormond Street Institute of Child Health<br />King's College London<br />London, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.lcu@notyalc.retep" class="oemail">ku.ca.lcu@notyalc.retep</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Susan J Hayflick</span>, MD<div class="affiliation small">Oregon Health and Science University<br />Portland, Oregon<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.usho@kcilfyah" class="oemail">ude.usho@kcilfyah</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Philippa B Mills</span>, PhD<div class="affiliation small">UCL Great Ormond Street Institute of Child Health<br />King's College London<br />London, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.lcu@sllim.p" class="oemail">ku.ca.lcu@sllim.p</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Manju A Kurian</span>, PhD<div class="affiliation small">UCL Great Ormond Street Institute of Child Health<br />King's College London<br />London, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.lcu@nairuk.ujnam" class="oemail">ku.ca.lcu@nairuk.ujnam</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">May 25, 2017</span>.</p><p><em>Estimated reading time: 14 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="slc39a14-def.Summary" itemprop="description"><h2 id="_slc39a14-def_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>SLC39A14 deficiency is characterized by evidence between ages six months and three years of delay or loss of motor developmental milestones (e.g., delayed walking, gait disturbance). Early in the disease course, children show axial hypotonia followed by dystonia, spasticity, dysarthria, bulbar dysfunction, and signs of parkinsonism including bradykinesia, hypomimia, and tremor. By the end of the first decade they develop severe, generalized, pharmaco-resistant dystonia, limb contractures, and scoliosis, and lose independent ambulation. Cognitive impairment appears to be less prominent than motor disability. Some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children have succumbed in their first decade due to secondary complications such as respiratory infections.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of SLC39A14 deficiency is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with progressive dystonia-parkinsonism (often combined with other signs such as spasticity and parkinsonian features), characteristic neuroimaging findings, hypermanganesemia, and <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>SLC39A14</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Symptomatic treatment includes physiotherapy and orthopedic management to prevent contractures and maintain ambulation; use of adaptive aids (walker or wheelchair) for gait abnormalities; and use of assistive communication devices. Support by a speech and language/feeding specialist and nutritionist to assure adequate nutrition and to reduce the risk of aspiration. When an adequate oral diet can no longer be maintained, gastrostomy tube placement should be considered. Antispasticity medications (baclofen and botulinum toxin) and L-dopa have had limited success. While chelation therapy with intravenous administration of disodium calcium edetate early in the disease course shows promise, additional studies are warranted.</p><p><i>Prevention of primary manifestations:</i> Unknown, but disodium calcium edetate chelation therapy shows promise; additional studies are warranted.</p><p><i>Surveillance:</i> Routine monitoring of:</p><ul><li class="half_rhythm"><div>Height and weight using age- and gender-appropriate growth charts;</div></li><li class="half_rhythm"><div>Swallowing and diet to assure adequate nutrition;</div></li><li class="half_rhythm"><div>Ambulation and speech;</div></li><li class="half_rhythm"><div>Whole-blood manganese levels and brain MRI to assess treatment response and disease progression.</div></li></ul><p><i>Agents/circumstances to avoid:</i></p><ul><li class="half_rhythm"><div>Environmental manganese exposure (i.e., contaminated drinking water, occupational manganese exposure in welding/mining industries, contaminated ephedrone preparations)</div></li><li class="half_rhythm"><div>High manganese content of total parenteral nutrition</div></li><li class="half_rhythm"><div>Foods very high in manganese, including: cloves; saffron; nuts; mussels; dark chocolate; pumpkin, sesame, and sunflower seeds</div></li></ul><p><i>Evaluation of relatives at risk:</i> Molecular genetic testing for the <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> <i>SLC39A14</i> pathogenic variants of apparently asymptomatic younger sibs of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual allows early identification of sibs who would benefit from prompt initiation of treatment and preventive measures.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>SLC39A14 deficiency is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Once the <i>SLC39A14</i> pathogenic variants have been identified in an affected family member, <a class="def" href="/books/n/gene/glossary/def-item/carrier-testing/">carrier testing</a> of at-risk relatives, prenatal testing for a pregnancy at increased risk, and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="slc39a14-def.Diagnosis"><h2 id="_slc39a14-def_Diagnosis_">Diagnosis</h2><div id="slc39a14-def.Suggestive_Findings"><h3>Suggestive Findings</h3><p>SLC39A14 deficiency <b>should be suspected</b> in individuals with typical clinical, neuroimaging, and laboratory findings [<a class="bk_pop" href="#slc39a14-def.REF.tuschl.2016.11601">Tuschl et al 2016</a>]:</p><ul><li class="half_rhythm"><div><b>Clinical findings.</b> Infantile or early-childhood onset of:</div><ul><li class="half_rhythm"><div>Delay in acquisition of developmental motor milestones or loss of developmental motor milestones;</div></li><li class="half_rhythm"><div>Progressive pharmaco-resistant dystonia;</div></li><li class="half_rhythm"><div>Parkinsonism signs (tremor, bradykinesia, hypomimia);</div></li><li class="half_rhythm"><div>Bulbar dysfunction;</div></li><li class="half_rhythm"><div>Dysarthria.</div></li></ul></li><li class="half_rhythm"><div><b>Neuroimaging.</b> Brain MRI findings characteristic of manganese deposition (<a class="figpopup" href="/books/NBK431123/figure/slc39a14-def.F1/?report=objectonly" target="object" rid-figpopup="figslc39a14defF1" rid-ob="figobslc39a14defF1">Figure 1</a>) including T<sub>1</sub>-weighted hyperintensity of the following:</div><ul><li class="half_rhythm"><div class="half_rhythm">Globus pallidus and striatum, with thalamic sparing;</div><div class="half_rhythm">Note: Basal ganglia changes on T<sub>1</sub>-weighted imaging are accompanied by T<sub>2</sub>-weighted hypointensity.</div></li><li class="half_rhythm"><div class="half_rhythm">White matter including the cerebellum, spinal cord, and dorsal pons, with sparing of the ventral pons;</div></li><li class="half_rhythm"><div class="half_rhythm">Anterior pituitary gland.</div></li></ul></li><li class="half_rhythm"><div><b>Laboratory findings.</b> Hypermanganesemia. Whole-blood manganese levels are markedly elevated, usually above 1,000 nmol/L (normal reference range &#x0003c;320 nmol/L).</div></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figslc39a14defF1" co-legend-rid="figlgndslc39a14defF1"><a href="/books/NBK431123/figure/slc39a14-def.F1/?report=objectonly" target="object" title="Figure 1" class="img_link icnblk_img figpopup" rid-figpopup="figslc39a14defF1" rid-ob="figobslc39a14defF1"><img class="small-thumb" src="/books/NBK431123/bin/slc39a14-def-Image001.gif" src-large="/books/NBK431123/bin/slc39a14-def-Image001.jpg" alt="Figure 1. A." /></a><div class="icnblk_cntnt" id="figlgndslc39a14defF1"><h4 id="slc39a14-def.F1"><a href="/books/NBK431123/figure/slc39a14-def.F1/?report=objectonly" target="object" rid-ob="figobslc39a14defF1">Figure 1</a></h4><p class="float-caption no_bottom_margin">A. Axial T<sub>1</sub>-weighted image showing the hyperintensity of the globus pallidus (white arrows), and the cerebral white matter (dashed arrows) B. Axial T<sub>2</sub>-weighted image showing the hypointensity of the globus pallidus (white arrows)</p></div></div></div><div id="slc39a14-def.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of SLC39A14 deficiency <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with progressive dystonia (often combined with other signs such as spasticity and parkinsonian features), characteristic neuroimaging findings, hypermanganesemia, and identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>SLC39A14</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> [<a class="bk_pop" href="#slc39a14-def.REF.tuschl.2016.11601">Tuschl et al 2016</a>] (see <a class="figpopup" href="/books/NBK431123/table/slc39a14-def.T.molecular_genetic_testing/?report=objectonly" target="object" rid-figpopup="figslc39a14defTmoleculargenetictesting" rid-ob="figobslc39a14defTmoleculargenetictesting">Table 1</a>).</p><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (single-gene testing or a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (comprehensive genomic sequencing) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of SLC39A14 deficiency is likely to be broad, children with the suggestive clinical, laboratory, and neuroimaging findings could be diagnosed using gene-targeted testing (see <a href="#slc39a14-def.Option_1">Option 1</a>), whereas those with early-onset dystonia-parkinsonism indistinguishable from other inherited disorders with parkinsonism-dystonia are more likely to be diagnosed using genomic testing (see <a href="#slc39a14-def.Option_2">Option 2</a>).</p><div id="slc39a14-def.Option_1"><h4>Option 1</h4><p>When the clinical, laboratory, and brain MRI findings suggest the diagnosis of SLC39A14 deficiency, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> and use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>.</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>SLC39A14</i> is performed first. If only one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> could be considered; however, to date no <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions have been reported.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>SLC39A14</i> and other genes of interest (see <a href="#slc39a14-def.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered.</div><div class="half_rhythm">Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> provides the best opportunity to identify the genetic cause of condition at the most reasonable cost while limiting identification of pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul></div><div id="slc39a14-def.Option_2"><h4>Option 2</h4><p>When the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is indistinguishable from other movement disorders, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (comprehensive genomic sequencing; recommended) or <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>; to consider).</p><ul><li class="half_rhythm"><div><b>Recommended testing.</b> Comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing (when available) includes <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>. For an introduction to comprehensive genomic testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li><li class="half_rhythm"><div><b>Testing to consider.</b> A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that includes <i>SLC39A14</i> and other genes of interest (see <a href="#slc39a14-def.Differential_Diagnosis">Differential Diagnosis</a>) may be considered; however, given the rarity of SLC39A14 deficiency, many panels for inherited dystonia-parkinsonism and/or this complex neurologic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> may not include this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>. For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><div id="slc39a14-def.T.molecular_genetic_testing" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in SLC39A14 Deficiency</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK431123/table/slc39a14-def.T.molecular_genetic_testing/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__slc39a14-def.T.molecular_genetic_testing_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_slc39a14-def.T.molecular_genetic_testing_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_slc39a14-def.T.molecular_genetic_testing_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_slc39a14-def.T.molecular_genetic_testing_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_slc39a14-def.T.molecular_genetic_testing_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC</i>3<i>9A14</i></td><td headers="hd_h_slc39a14-def.T.molecular_genetic_testing_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_slc39a14-def.T.molecular_genetic_testing_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7/7&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_slc39a14-def.T.molecular_genetic_testing_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>4</sup></td><td headers="hd_h_slc39a14-def.T.molecular_genetic_testing_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="slc39a14-def.TF.1.1"><p class="no_margin">See <a href="/books/NBK431123/#slc39a14-def.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="slc39a14-def.TF.1.2"><p class="no_margin">See <a href="#slc39a14-def.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="slc39a14-def.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="slc39a14-def.TF.1.4"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>5. </dt><dd><div id="slc39a14-def.TF.1.5"><p class="no_margin">No data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available.</p></div></dd><dt>6. </dt><dd><div id="slc39a14-def.TF.1.6"><p class="no_margin">Five reported <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> families [<a class="bk_pop" href="#slc39a14-def.REF.tuschl.2016.11601">Tuschl et al 2016</a>] and two other families, one consanguineous and one non-consanguineous [Author, personal observation]</p></div></dd></dl></div></div></div></div></div></div><div id="slc39a14-def.Clinical_Characteristics"><h2 id="_slc39a14-def_Clinical_Characteristics_">Clinical Characteristics</h2><div id="slc39a14-def.Clinical_Description"><h3>Clinical Description</h3><p>SLC39A14 deficiency has only recently been identified in 11 individuals from seven families [<a class="bk_pop" href="#slc39a14-def.REF.tuschl.2016.11601">Tuschl et al 2016</a>; Author, personal observation]; therefore, information on the phenotypic spectrum and disease progression is limited.</p><p>Onset occurs between ages six months and three years. Affected children present with delay or loss of motor developmental milestones (e.g., delayed walking, gait disturbance).</p><p>Early in the disease course, children show axial hypotonia followed by dystonia, spasticity, dysarthria, bulbar dysfunction, and signs of parkinsonism including bradykinesia, hypomimia, and tremor.</p><p>By the end of the first decade, they develop severe, generalized, pharmaco-resistant dystonia, limb contractures, scoliosis, and loss of independent ambulation.</p><p>Although there appears to be relative cognitive sparing (psychometric testing has not been possible), a degree of learning disability is present in all children.</p><p>Some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children succumb in their first decade due to secondary complications such as respiratory infections.</p><p><b>Neuropathology.</b> The neuropathologic findings in one individual with SLC39A14 deficiency [<a class="bk_pop" href="#slc39a14-def.REF.tuschl.2016.11601">Tuschl et al 2016</a>] included:</p><ul><li class="half_rhythm"><div>Extensive gliosis and neuronal loss in the globus pallidus and dentate nucleus;</div></li><li class="half_rhythm"><div>Preservation of neurons in the cerebral and cerebellar cortex as well as the caudate, putamen, and thalamus;</div></li><li class="half_rhythm"><div>A vacuolated myelinopathy with patchy axonal loss in the cerebral and cerebellar white matter.</div></li></ul></div><div id="slc39a14-def.GenotypePhenotype_Correlati"><h3>Genotype-Phenotype Correlations</h3><p>No <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> are known.</p></div><div id="slc39a14-def.Prevalence"><h3>Prevalence</h3><p>The disease prevalence is not established. To date only 11 individuals with SLC39A14 deficiency from seven families have been identified. These seven families are from different ethnic backgrounds and six are <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> [<a class="bk_pop" href="#slc39a14-def.REF.tuschl.2016.11601">Tuschl et al 2016</a>; Author, personal observation].</p></div></div><div id="slc39a14-def.Genetically_Related_Allelic"><h2 id="_slc39a14-def_Genetically_Related_Allelic_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>SLC39A14</i>.</p></div><div id="slc39a14-def.Differential_Diagnosis"><h2 id="_slc39a14-def_Differential_Diagnosis_">Differential Diagnosis</h2><div id="slc39a14-def.T.disorders_to_consider_in" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Disorders to Consider in the Differential Diagnosis of SLC39A14 Deficiency</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK431123/table/slc39a14-def.T.disorders_to_consider_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__slc39a14-def.T.disorders_to_consider_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_1" rowspan="2" colspan="2" scope="colgroup" headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Clinical Features of This Disorder</th></tr><tr><th headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_4" id="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping with SLC39A14 Deficiency</th><th headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_4" id="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from SLC39A14 Deficiency</th></tr></thead><tbody><tr><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Disorders of manganese homeostasis</b></td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/hmdpc/">Dystonia/parkinsonism, hypermanganesemia, polycythemia, and chronic liver disease</a> (SLC30A10 deficiency)</td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC30A10</i></td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_4 hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_2_1" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Dystonia-parkinsonism</div></li><li class="half_rhythm"><div>Hypermanganesemia</div></li><li class="half_rhythm"><div>Brain MRI features consistent w/manganese deposition</div></li></ul>
</td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_4 hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Presents with polycythemia, abnormal iron indices, &#x00026; liver disease in addition to the neurologic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a></div></li><li class="half_rhythm"><div>Absence of Mn deposition in the liver w/T<sub>1</sub> hyperintensity on liver MRI</div></li></ul>
</td></tr><tr><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Acquired hypermanganesemia&#x000a0;<sup>1</sup></td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N/A</td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N/A</td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_4 hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_2_2" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Often presents w/psychiatric symptoms</div></li><li class="half_rhythm"><div>History of Mn exposure from environmental sources, parenteral nutrition, or contaminated ephedrone preparations</div></li></ul>
</td></tr><tr><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Acquired hepatocerebral degeneration&#x000a0;<sup>2</sup></td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N/A</td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N/A</td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_4 hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_2_2" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Liver disease is the predominant feature; it precedes development of neurologic symptoms.</div></li></ul>
</td></tr><tr><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_1" rowspan="7" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Early-onset NBIA disorders</b> (see <a href="/books/n/gene/nbia-ov/">NBIA Overview</a>)</td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/pkan/">PKAN</a></td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PANK2</i></td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_4 hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_2_1" rowspan="7" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Parkinsonism-dystonia</div></li><li class="half_rhythm"><div>T<sub>2</sub>-weighted hypointensity of the globus pallidus on brain MRI</div></li></ul>
</td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_4 hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_2_2" rowspan="7" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Usually presents w/additional clinical features (e.g., pigmentary retinopathy, optic atrophy, oculomotor abnormalities, axonal neuropathy, cognitive decline, seizures)</div></li><li class="half_rhythm"><div>Lacks the T<sub>1</sub>-weighted hyperintensity of the globus pallidus on brain MRI due to Mn deposition</div></li></ul>
</td></tr><tr><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/inad/">PLAN</a></td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PLA2G6</i></td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/mt-mpan/">MPAN</a></td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>C19orf12</i></td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/bpan/">BPAN</a></td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>WDR45</i></td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td></tr><tr><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/fahn/">FAHN</a></td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FA2H</i></td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Kufor-Rakeb syndrome</td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ATP13A2</i></td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">CoPAN</td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COASY</i></td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Disorders of copper metabolism</b></td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/wilson/">Wilson disease</a></td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ATP7B</i></td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_4 hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Parkinsonism-dystonia</div></li></ul>
</td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_4 hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Liver disease, psychiatric symptoms, low serum ceruloplasmin &#x00026; high non-ceruloplasmin-bound serum copper</div></li><li class="half_rhythm"><div>No Mn deposition on brain MRI</div></li></ul>
</td></tr><tr><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_1" rowspan="7" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Inherited forms of dystonia</b> (see <a href="/books/n/gene/dystonia-ov/">Dystonia Overview</a>)</td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/dystonia/">DYT1 early-onset isolated dystonia</a></td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TOR1A</i></td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_4 hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_2_1" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Early-onset generalized dystonia</div></li></ul>
</td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_4 hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_2_2" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>No features consistent w/Mn deposition on brain MRI</div></li><li class="half_rhythm"><div>Absent hypermanganesemia</div></li></ul>
</td></tr><tr><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/kmt2b-dystonia/"><i>KMT2B</i>-related early-onset dystonia</a></td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KMT2B</i></td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>MECR</i>-related childhood-onset dystonia and optic atrophy&#x000a0;<sup>3</sup></td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MECR</i></td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_4 hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_2_2" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Additional optic atrophy</div></li><li class="half_rhythm"><div>No features consistent w/Mn deposition on brain MRI</div></li></ul>
</td></tr><tr><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/slc6a3-dtds/"><i>SLC6A3</i>-related dopamine transporter deficiency syndrome</a></td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC6A3</i></td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_4 hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_2_1" rowspan="5" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Parkinsonism-dystonia</div></li></ul>
</td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_4 hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_2_2" rowspan="5" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>No features consistent w/Mn deposition on brain MRI</div></li></ul>
</td></tr><tr><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/thdrd/">Tyrosine hydroxylase-deficient dopa-responsive dystonia</a></td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TH</i></td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/drd/">GTP cyclohydrolase 1-deficient dopa-responsive dystonia</a></td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GCH1</i></td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>AD</i></td></tr><tr><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/spr-def/">Sepiapterin reductase deficiency dopa-responsive dystonia</a></td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SPR</i></td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_1 hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_2 hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_3" colspan="4" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Inherited Forms of Parkinson Disease</b> (see <a href="/books/n/gene/parkinson-overview/">Parkinson Disease Overview</a>)</td></tr><tr><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_1 hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_2 hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_3" colspan="4" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Inherited neurodegenerative/metabolic disorders</b><br />(see <a href="/books/n/gene/dystonia-ov/#dystonia-ov.table4">Dystonia Overview, Table 4</a> for hereditary neurodegenerative or metabolic<br />disorders characterized by complex dystonia)</td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_4 hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Complex dystonia</div></li></ul>
</td><td headers="hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_1_4 hd_h_slc39a14-def.T.disorders_to_consider_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>No features consistent w/Mn deposition on brain MRI</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; BPAN = beta-propeller protein-associated neurodegeneration; CoPAN = COASY protein-associated neurodegeneration; FAHN = fatty acid hydroxylase-associated neurodegeneration. Mn = manganese; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; MPAN = mitochondrial membrane protein-associated neurodegeneration; NBIA = neurodegeneration with brain iron accumulation; PKAN = pantothenate kinase-associated neurodegeneration; PLAN = <i>PLA2G6</i>-associated neurodegeneration; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="slc39a14-def.TF.2.1"><p class="no_margin"><a class="bk_pop" href="#slc39a14-def.REF.mortimer.2012.1174">Mortimer et al [2012]</a>, <a class="bk_pop" href="#slc39a14-def.REF.santos.2014.36">Santos et al [2014]</a>, <a class="bk_pop" href="#slc39a14-def.REF.janochalitwin.2015.832">Janocha-Litwin et al [2015]</a></p></div></dd><dt>2. </dt><dd><div id="slc39a14-def.TF.2.2"><p class="no_margin"><a class="bk_pop" href="#slc39a14-def.REF.mileti_.2014.207">Mileti&#x00107; et al [2014]</a></p></div></dd><dt>3. </dt><dd><div id="slc39a14-def.TF.2.3"><p class="no_margin"><a class="bk_pop" href="#slc39a14-def.REF.heimer.2016.1229">Heimer et al [2016]</a></p></div></dd></dl></div></div></div></div><div id="slc39a14-def.Management"><h2 id="_slc39a14-def_Management_">Management</h2><div id="slc39a14-def.Evaluations_Following_Initi"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with SLC39A14 deficiency, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Neurologic examination for dystonia, parkinsonism, and spasticity, including evaluation of ambulation and speech</div></li><li class="half_rhythm"><div>Assessment for physiotherapy, occupational therapy, and/or speech therapy</div></li><li class="half_rhythm"><div>Evaluation of swallowing and nutritional status</div></li><li class="half_rhythm"><div>Brain MRI, if not performed as part of the diagnostic evaluation</div></li><li class="half_rhythm"><div>Assessment of whole-blood manganese levels, if not performed as part of the diagnostic evaluation</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="slc39a14-def.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>Symptomatic treatment.</b> Early initiation of physiotherapy and orthopedic management aims to prevent contractures and maintain ambulation. As needed, individuals should be referred for adaptive aids (e.g., a walker or wheelchair for gait abnormalities) and assistive communication devices.</p><p>Support by a speech and language/feeding specialist and nutritionist is indicated to assure adequate nutrition and to reduce the risk of aspiration. When an adequate oral diet can no longer be maintained, gastrostomy tube placement should be considered. Gastric feeding tube and/or tracheostomy may be required to prevent aspiration pneumonia.</p><p>Note that symptomatic treatment with L-dopa and antispasticity medications including benzodiazepines, baclofen, and botulinum toxin has been attempted with limited success. There has been partial but poorly sustained response to trihexyphenidyl at high doses of 20 mg/day and intrathecal baclofen of 1,500-2,000 &#x000b5;g/day in two older sibs reported by <a class="bk_pop" href="#slc39a14-def.REF.tuschl.2016.11601">Tuschl et al [2016]</a>.</p><p><b>Chelation therapy.</b> Disodium calcium edetate, which primarily promotes the urinary excretion of manganese, was given intravenously (20 mg/kg/dose) twice daily for five days each month to a female age five years with SLC39A14 deficiency [<a class="bk_pop" href="#slc39a14-def.REF.tuschl.2016.11601">Tuschl et al 2016</a>]. After six months of treatment, neurologic manifestations improved and the child regained the ability to walk.</p><p>In contrast, treatment of a female age 17 years with advanced disease (severe generalized dystonia with prominent oromandibular involvement, contractures, and scoliosis) did not affect disease progression as she continued to deteriorate with worsening tremor and stiffness. Hence, it is likely necessary to initiate chelation treatment early in the disease course.</p><p>It is anticipated that chelation therapy will need to be lifelong.</p><p>Potential adverse effects of disodium calcium edetate chelation therapy include thrombocytopenia and leukopenia, nephrotoxicity, hepatoxicity, hypocalcemia, and trace metal and vitamin deficiencies [<a class="bk_pop" href="#slc39a14-def.REF.lamas.2012.7">Lamas et al 2012</a>]. Monitoring includes the following:</p><ul><li class="half_rhythm"><div>Complete blood count</div></li><li class="half_rhythm"><div>Assessment of renal function including urinalysis assessed at baseline and monthly thereafter. Monitoring may be extended to every other month once on a stable dose.</div></li><li class="half_rhythm"><div>Assessment of liver function</div></li><li class="half_rhythm"><div>Measurement of the concentrations of electrolytes, calcium, magnesium, and phosphate</div></li><li class="half_rhythm"><div>Measurement of the concentrations of trace metals (manganese, zinc, copper, and selenium)</div></li><li class="half_rhythm"><div>Assessment of iron status</div></li></ul><p>Treatment may need to be discontinued if:</p><ul><li class="half_rhythm"><div>White blood count is &#x0003c;3.5x10<sup>9</sup>/L</div></li><li class="half_rhythm"><div>Neutrophil count is &#x0003c;2.0x10<sup>9</sup>/L</div></li><li class="half_rhythm"><div>Platelet count is &#x0003c;150x10<sup>9</sup>/L</div></li><li class="half_rhythm"><div>&#x0003e;2+ proteinuria is detected on more than one occasion (with no evidence of infection)</div></li></ul><p>The above cut-off values are based on guidelines for D-penicillamine treatment [<a class="bk_pop" href="#slc39a14-def.REF.chakravarty.2008.924">Chakravarty et al 2008</a>]. Because chelation treatment with disodium calcium edetate may prevent early death and reduce morbidity in SLC39A14 deficiency, lower cut-off values may be acceptable. For each <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual, the benefits of clinical treatment need to be carefully weighed against the risk of adverse effects.</p></div><div id="slc39a14-def.Prevention_of_Primary_Manif"><h3>Prevention of Primary Manifestations</h3><p>Chelation therapy with disodium calcium edetate may prevent primary disease manifestations in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> sibs who are asymptomatic (see <a href="#slc39a14-def.Treatment_of_Manifestations">Treatment of Manifestations</a>).</p></div><div id="slc39a14-def.Surveillance"><h3>Surveillance</h3><p>Routine monitoring of:</p><ul><li class="half_rhythm"><div>Height and weight using age and gender appropriate growth charts;</div></li><li class="half_rhythm"><div>Swallowing and diet to assure adequate nutrition;</div></li><li class="half_rhythm"><div>Ambulation and speech;</div></li><li class="half_rhythm"><div>Whole-blood manganese levels and brain MRI to assess treatment response and disease progression.</div></li></ul></div><div id="slc39a14-def.AgentsCircumstances_to_Avoi"><h3>Agents/Circumstances to Avoid</h3><p>The following should be avoided:</p><ul><li class="half_rhythm"><div>Environmental manganese exposure (i.e., contaminated drinking water, occupational manganese exposure in welding/mining industries, contaminated ephedrone preparations)</div></li><li class="half_rhythm"><div>High manganese content of total parenteral nutrition</div></li><li class="half_rhythm"><div>Foods very high in manganese, including: cloves; saffron; nuts; mussels; dark chocolate; and pumpkin, sesame, and sunflower seeds</div></li></ul></div><div id="slc39a14-def.Evaluation_of_Relatives_at"><h3>Evaluation of Relatives at Risk</h3><p>Molecular genetic testing of apparently asymptomatic younger sibs of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual for the <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> <i>SLC39A14</i> pathogenic variants allows early identification of sibs who would benefit from prompt initiation of treatment and preventive measures (see <a href="#slc39a14-def.AgentsCircumstances_to_Avoi">Agents/Circumstances to Avoid</a>).</p><p>See <a href="#slc39a14-def.Related_Genetic_Counseling">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="slc39a14-def.Therapies_Under_Investigati"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="slc39a14-def.Genetic_Counseling"><h2 id="_slc39a14-def_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="slc39a14-def.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>SLC39A14 deficiency is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. Six of the seven families reported to date were <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a>.</p><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one <i>SLC39A14</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with SLC39A14 deficiency are obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SLC39A14</i>.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <i>SLC39A14</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="slc39a14-def.Carrier_Heterozygote_Detect"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>SLC39A14</i> pathogenic variants in the family. Carrier testing for reproductive partners of known carriers is appropriate, particularly if <a class="def" href="/books/n/gene/glossary/def-item/consanguinity/">consanguinity</a> is likely.</p></div><div id="slc39a14-def.Related_Genetic_Counseling"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#slc39a14-def.Evaluation_of_Relatives_at">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="slc39a14-def.Prenatal_Testing_and_Preimp"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>SLC39A14</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="slc39a14-def.Resources"><h2 id="_slc39a14-def_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><p>No specific resources for SLC39A14 Deficiency have been identified by <i>GeneReviews</i> staff.</p></div><div id="slc39a14-def.Molecular_Genetics"><h2 id="_slc39a14-def_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="slc39a14-def.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>SLC39A14 Deficiency: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK431123/table/slc39a14-def.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__slc39a14-def.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_slc39a14-def.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_slc39a14-def.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_slc39a14-def.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_slc39a14-def.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_slc39a14-def.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_slc39a14-def.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/23516" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SLC39A14</i></a></td><td headers="hd_b_slc39a14-def.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=23516" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">8p21<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_slc39a14-def.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q15043" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Zinc transporter ZIP14</a></td><td headers="hd_b_slc39a14-def.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SLC39A14" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SLC39A14</a></td><td headers="hd_b_slc39a14-def.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SLC39A14[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SLC39A14</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="slc39a14-def.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="slc39a14-def.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for SLC39A14 Deficiency (<a href="/omim/608736,617013" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK431123/table/slc39a14-def.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__slc39a14-def.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/608736" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">608736</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 14; SLC39A14</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/617013" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">617013</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HYPERMANGANESEMIA WITH DYSTONIA 2; HMNDYT2</td></tr></tbody></table></div></div><div id="slc39a14-def.Molecular_Genetic_Pathogene"><h3>Molecular Genetic Pathogenesis</h3><p><i>SLC39A14</i> encodes a divalent metal transporter that is required for cellular uptake of manganese [<a class="bk_pop" href="#slc39a14-def.REF.tuschl.2016.11601">Tuschl et al 2016</a>]. It plays a crucial role as a regulator of manganese homeostasis by facilitating manganese uptake into the liver for subsequent excretion in bile.</p><p>Biallelic <i>SLC39A14</i> pathogenic variants are thought to impair hepatic manganese uptake and lead to accumulation of manganese in the blood. Subsequent deposition of manganese in the brain, particularly the globus pallidus, results in manganese toxicity and causes progressive dystonia (often combined with other signs such as spasticity and parkinsonian features) [<a class="bk_pop" href="#slc39a14-def.REF.tuschl.2016.11601">Tuschl et al 2016</a>].</p><p><b>Gene structure.</b>
<i>SLC39A14</i> comprises nine exons and encodes four transcripts. Two transcripts differ by an alternative 5'UTR (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001128431.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001128431.2</a> and <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001135153" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001135153</a>). Alternative <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 4 and 9 generates two alternative transcripts (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_015359.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_015359.4</a> and <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001135154.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001135154.1</a>).</p><p><b>Pathogenic variants.</b> Homozygous or <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> <i>SLC39A14</i> pathogenic variants documented in seven families include <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> and <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> variants (see <a class="figpopup" href="/books/NBK431123/table/slc39a14-def.T.slc39a14_variants_discuss/?report=objectonly" target="object" rid-figpopup="figslc39a14defTslc39a14variantsdiscuss" rid-ob="figobslc39a14defTslc39a14variantsdiscuss">Table 3</a>).</p><p>Pathogenic variants are predicted to (1) cause a significantly truncated protein because of a frameshift and premature stop codon, (2) affect an evolutionary highly conserved area of the protein, or (3) lead to abnormal <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a>. Therefore, these sequence changes have detrimental effects on protein function [<a class="bk_pop" href="#slc39a14-def.REF.tuschl.2016.11601">Tuschl et al 2016</a>].</p><div id="slc39a14-def.T.slc39a14_variants_discuss" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p><i>SLC39A14</i> Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK431123/table/slc39a14-def.T.slc39a14_variants_discuss/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__slc39a14-def.T.slc39a14_variants_discuss_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_slc39a14-def.T.slc39a14_variants_discuss_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_slc39a14-def.T.slc39a14_variants_discuss_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_slc39a14-def.T.slc39a14_variants_discuss_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_slc39a14-def.T.slc39a14_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.292T&#x0003e;G</td><td headers="hd_h_slc39a14-def.T.slc39a14_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Phe98Val</td><td headers="hd_h_slc39a14-def.T.slc39a14_variants_discuss_1_1_1_3" rowspan="8" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_015359.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_015359<wbr style="display:inline-block"></wbr>​.4</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_056174.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_056174<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_slc39a14-def.T.slc39a14_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.313G&#x0003e;T</td><td headers="hd_h_slc39a14-def.T.slc39a14_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu105Ter</td></tr><tr><td headers="hd_h_slc39a14-def.T.slc39a14_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.367C&#x0003e;T</td><td headers="hd_h_slc39a14-def.T.slc39a14_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln123Ter</td></tr><tr><td headers="hd_h_slc39a14-def.T.slc39a14_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.477_478delCA</td><td headers="hd_h_slc39a14-def.T.slc39a14_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser160CysfsTer5</td></tr><tr><td headers="hd_h_slc39a14-def.T.slc39a14_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.512G&#x0003e;A</td><td headers="hd_h_slc39a14-def.T.slc39a14_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly171Glu</td></tr><tr><td headers="hd_h_slc39a14-def.T.slc39a14_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1147G&#x0003e;A</td><td headers="hd_h_slc39a14-def.T.slc39a14_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly383Arg</td></tr><tr><td headers="hd_h_slc39a14-def.T.slc39a14_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1407C&#x0003e;G</td><td headers="hd_h_slc39a14-def.T.slc39a14_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn469Lys</td></tr><tr><td headers="hd_h_slc39a14-def.T.slc39a14_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.751-9C&#x0003e;G&#x000a0;<sup>1,&#x000a0;2</sup></td><td headers="hd_h_slc39a14-def.T.slc39a14_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.His251ProfsTer26&#x000a0;<sup>1</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="slc39a14-def.TF.3.1"><p class="no_margin"><a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> analysis confirmed an eight-nucleotide <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> (c.751_752insCTTCCAGC) from <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> 5 indicating that this variant creates a new splice-acceptor site [Author, personal observation].</p></div></dd><dt>2. </dt><dd><div id="slc39a14-def.TF.3.2"><p class="no_margin">g.22,273,273C&#x0003e;G (GRCh37/hg19)</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>SLC39A14</i> encodes three protein <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a>. Isoforms 1 (<a href="https://www.ncbi.nlm.nih.gov/protein/NP_001121903" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001121903</a>) and 2 (<a href="https://www.ncbi.nlm.nih.gov/protein/NP_056174.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_056174</a>) have 492 amino acids; isoform 3 (<a href="https://www.ncbi.nlm.nih.gov/protein/NP_001128626" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001128626</a>) has 481 amino acids. They contain eight transmembrane domains, a histidine-rich motif (HXHXHX), and a metalloprotease motif (H/EEXPHEXGD) required for metal transport [<a class="bk_pop" href="#slc39a14-def.REF.taylor.2005.427">Taylor et al 2005</a>, <a class="bk_pop" href="#slc39a14-def.REF.tominaga.2005.1590">Tominaga et al 2005</a>].</p><p>Only <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> 1 and 2 have been studied in detail; both localize to the plasma membrane and transport manganese, iron, zinc, and cadmium. While isoform 1 is ubiquitously expressed, expression of isoform 2 is restricted to liver, gastrointestinal tract, kidney, and pancreas with no expression in the brain. Isoform 2 is thought to act as the main regulator of manganese homeostasis, facilitating hepatic manganese uptake for biliary excretion [<a class="bk_pop" href="#slc39a14-def.REF.tuschl.2016.11601">Tuschl et al 2016</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>SLC39A14</i> pathogenic variants described in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals (<a class="figpopup" href="/books/NBK431123/table/slc39a14-def.T.slc39a14_variants_discuss/?report=objectonly" target="object" rid-figpopup="figslc39a14defTslc39a14variantsdiscuss" rid-ob="figobslc39a14defTslc39a14variantsdiscuss">Table 3</a>) have deleterious effects on protein function. While <a class="def" href="/books/n/gene/glossary/def-item/wild-type/">wild-type</a> SLC39A14 expressed in HEK-293 cells facilitates manganese uptake, mutated SLC39A14 results in greatly reduced manganese uptake [<a class="bk_pop" href="#slc39a14-def.REF.tuschl.2016.11601">Tuschl et al 2016</a>].</p></div></div><div id="slc39a14-def.References"><h2 id="_slc39a14-def_References_">References</h2><div id="slc39a14-def.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="slc39a14-def.REF.chakravarty.2008.924">Chakravarty K, McDonald H, Pullar T, Taggart A, Chalmers R, Oliver S, Mooney J, Somerville M, Bosworth A, Kennedy T. BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists. <span><span class="ref-journal">Rheumatology. </span>2008;<span class="ref-vol">47</span>:924–5.</span> [<a href="/pubmed/16940305" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16940305</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc39a14-def.REF.heimer.2016.1229">Heimer G, Ker&#x000e4;t&#x000e4;r JM, Riley LG, Balasubramaniam S, Eyal E, Pietik&#x000e4;inen LP, Hiltunen JK, Marek-Yagel D, Hamada J, Gregory A, Rogers C, Hogarth P, Nance MA, Shalva N, Veber A, Tzadok M, Nissenkorn A, Tonduti D, Renaldo F, Kraoua I, Panteghini C, Valletta L, Garavaglia B, Cowley MJ, Gayevskiy V, Roscioli T, Silberstein JM, Hoffmann C, Raas-Rothschild A, Tiranti V, Anikster Y, Christodoulou J, Kastaniotis AJ, Ben-Zeev B, Hayflick SJ, et al.  MECR mutations cause childhood-onset dystonia and optic atrophy, a mitochondrial fatty acid synthesis disorder. <span><span class="ref-journal">Am J Hum Genet. </span>2016;<span class="ref-vol">99</span>:1229–44.</span> [<a href="/pmc/articles/PMC5142118/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5142118</span></a>] [<a href="/pubmed/27817865" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27817865</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc39a14-def.REF.janochalitwin.2015.832">Janocha-Litwin J, Marianska K, Serafinska S, Simon K. Manganese encephalopathy among ephedron abusers. <span><span class="ref-journal">J Neuroimaging. </span>2015;<span class="ref-vol">25</span>:832–5.</span> [<a href="/pubmed/25255816" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25255816</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc39a14-def.REF.lamas.2012.7">Lamas GA, Goertz C, Boineau R, Mark DB, Rozema T, Nahin RL, Drisko JA, Lee KL. Design of the trial to assess chelation therapy (TACT). <span><span class="ref-journal">Am Heart J. </span>2012;<span class="ref-vol">163</span>:7–12.</span> [<a href="/pmc/articles/PMC3243954/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3243954</span></a>] [<a href="/pubmed/22172430" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22172430</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc39a14-def.REF.mileti_.2014.207">Mileti&#x00107; V, Ozreti&#x00107; D, Relja M. Parkinsonian syndrome and ataxia as a presenting finding of acquired hepatocerebral degeneration. <span><span class="ref-journal">Metab Brain Dis. </span>2014;<span class="ref-vol">29</span>:207–9.</span> [<a href="/pubmed/24390157" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24390157</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc39a14-def.REF.mortimer.2012.1174">Mortimer JA, Borenstein AR, Nelson LM. Associations of welding and manganese exposure with Parkinson disease: review and meta-analysis. <span><span class="ref-journal">Neurology. </span>2012;<span class="ref-vol">79</span>:1174–80.</span> [<a href="/pmc/articles/PMC3525308/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3525308</span></a>] [<a href="/pubmed/22965675" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22965675</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc39a14-def.REF.santos.2014.36">Santos D, Batoreu C, Mateus L, Marreilha Dos Santos AP, Aschner M. Manganese in human parenteral nutrition: considerations for toxicity and biomonitoring. <span><span class="ref-journal">Neurotoxicology. </span>2014;<span class="ref-vol">43</span>:36–45.</span> [<a href="/pmc/articles/PMC4007395/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4007395</span></a>] [<a href="/pubmed/24184781" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24184781</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc39a14-def.REF.taylor.2005.427">Taylor KM, Morgan HE, Johnson A, Nicholson RI. Structure-function analysis of a novel member of the LIV-1 subfamily of zinc transporters, ZIP14. <span><span class="ref-journal">FEBS Lett. </span>2005;<span class="ref-vol">579</span>:427–32.</span> [<a href="/pubmed/15642354" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15642354</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc39a14-def.REF.tominaga.2005.1590">Tominaga K, Kagata T, Johmura Y, Hishida T, Nishizuka M, Imagawa M. SLC39A14, a LZT protein, is induced in adipogenesis and transports zinc. <span><span class="ref-journal">FEBS J. </span>2005;<span class="ref-vol">272</span>:1590–99.</span> [<a href="/pubmed/15794747" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15794747</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc39a14-def.REF.tuschl.2016.11601">Tuschl K, Meyer E, Valdivia LE, Zhao N, Dadswell C, Abdul-Sada A, Hung CY, Simpson MA, Chong WK, Jacques TS, Woltjer RL, Eaton S, Gregory A, Sanford L, Kara E, Houlden H, Cuno SM, Prokisch H, Valletta L, Tiranti V, Younis R, Maher ER, Spencer J, Straatman-Iwanowska A, Gissen P, Selim LA, Pintos-Morell G, Coroleu-Lletget W, Mohammad SS, Yoganathan S, Dale RC, Thomas M, Rihel J, Bodamer OA, Enns CA, Hayflick SJ, Clayton PT, Mills PB, Kurian MA, Wilson SW. Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism-dystonia. <span><span class="ref-journal">Nat Commun. </span>2016;<span class="ref-vol">7</span>:11601.</span> [<a href="/pmc/articles/PMC4894980/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4894980</span></a>] [<a href="/pubmed/27231142" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27231142</span></a>]</div></li></ul></div></div><div id="slc39a14-def.Chapter_Notes"><h2 id="_slc39a14-def_Chapter_Notes_">Chapter Notes</h2><div id="slc39a14-def.Acknowledgments"><h3>Acknowledgments</h3><p>This work was supported by grants from Action Medical Research, the Wellcome Trust, Great Ormond Street Hospital Children's Charity, NBIA Disorders Association, Gracious Heart Charity Foundation and Rosetrees Trust, and the GOSH National Institute for Health Research/Biomedical Research Centre.</p></div><div id="slc39a14-def.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>25 May 2017 (bp) Review posted live</div></li><li class="half_rhythm"><div>29 November 2016 (kt) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK431123</span><span class="label">PMID: <a href="/pubmed/28541650" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">28541650</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/slc12a5-e/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/slc6a3-dtds/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK431123&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK431123/?report=reader">PubReader</a></li><li><a href="/books/NBK431123/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK431123" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK431123" style="display:none" title="Cite this Page"><div class="bk_tt">Tuschl K, Gregory A, Meyer E, et al. SLC39A14 Deficiency. 2017 May 25. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK431123/pdf/Bookshelf_NBK431123.pdf">PDF version of this page</a> (577K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#slc39a14-def.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#slc39a14-def.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#slc39a14-def.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#slc39a14-def.Genetically_Related_Allelic" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#slc39a14-def.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#slc39a14-def.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#slc39a14-def.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#slc39a14-def.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#slc39a14-def.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#slc39a14-def.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#slc39a14-def.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=23516[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SLC39A14</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4399824" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4399824" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4399824" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4399824" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22934317" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Dystonia/Parkinsonism, Hypermanganesemia, Polycythemia, and Chronic Liver Disease</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Dystonia/Parkinsonism, Hypermanganesemia, Polycythemia, and Chronic Liver Disease<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Tuschl K, Clayton PT, Gospe SM Jr, Mills PB. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301610" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Tyrosine Hydroxylase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Tyrosine Hydroxylase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Furukawa Y, Kish S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301718" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PLA2G6</i>-Associated Neurodegeneration</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PLA2G6</i>-Associated Neurodegeneration<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gregory A, Kurian MA, Maher ER, Hogarth P, Hayflick SJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28749637" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SLC6A3</i>-Related Dopamine Transporter Deficiency Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SLC6A3</i>-Related Dopamine Transporter Deficiency Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kurian MA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/26072523" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Riboflavin Transporter Deficiency Neuronopathy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Riboflavin Transporter Deficiency Neuronopathy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Manole A, Houlden H. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=28541650" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=28541650" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040fcadde08911697b6aee">SLC39A14 Deficiency - GeneReviews®</a><div class="ralinkpop offscreen_noflow">SLC39A14 Deficiency - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:41:30-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE88D9D1E040B7A10000000001BB00A2&amp;ncbi_session=CE88D9D1E040FC91_0443SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK431123%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK431123&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK431123/&amp;ncbi_pagename=SLC39A14 Deficiency - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE88D9D1E040FC91_0443SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>